Clinical trial
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
NCT02787044 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 1, 2016
- Completion date
- May 31, 2020
- Enrollment
- 5,388 (actual)
- Sites
- 190
Conditions
As the registry lists them; a condition with its own page is linked.